Study of the Intracerebral Electrophysiological Signature in the Epileptic Patient
ACTELIN 2
2 other identifiers
observational
75
1 country
1
Brief Summary
As part of the clinical management of certain severe, drug-resistant forms of epilepsy, it is necessary to implant electrodes in the brain to identify the epileptic network prior to potential neurosurgical resection of the source zones. This standardized procedure, known as Stereo-Electroencephalography (SEEG), was developed in France in the 1960s. The electrodes remain implanted for several days-typically two weeks-while awaiting spontaneous epileptic seizures. During this period, the patient remains hospitalized, and their electroencephalographic activity is recorded around the clock. Patients can be asked to perform cognitive tasks (such as tasks involving memory, attention, vision, language, and decision-making) while awake or asleep; the results can then be correlated with the intracerebral electroencephalographic activity recorded simultaneously as part of their clinical care. This approach makes it possible to capture the electrophysiological signatures of specific cognitive processes, thereby enabling researchers to: 1) create a brain map of electrophysiological signatures, 2) improve standard models of cognitive function, and 3) study the dysfunction of these processes in epilepsy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2026
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2026
CompletedFirst Posted
Study publicly available on registry
September 1, 2026
CompletedStudy Start
First participant enrolled
October 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2031
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 31, 2031
September 1, 2026
August 1, 2026
5 years
August 27, 2026
August 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Construction of a database of electrophysiological signatures of various cognitive functions
Correlation of performance on a task involving a neurocognitive process with characteristics of brain activity recorded during the task (electrophysiological signature) using intracranial stereo-electroencephalography (SEEG) electrodes.
3 weeks after the inclusion
Secondary Outcomes (2)
Evaluation of the impact of epilepsy on these electrophysiological signatures
3 weeks after the inclusion
Determine whether a given brain region is dysfunctional in certain epileptic patients by comparing it with the atlas of normal physiological signatures.
3 weeks after the inclusion
Study Arms (1)
Patients hospitalized for SEEG with cognitive tasks
Interventions
During their hospitalization for SEEG, patients will perform cognitive tasks to assess memory, vision, attention, language, and decision-making.
Eligibility Criteria
patients with drug-resistant epilepsy hospitalized for stereo-electroencephalography
You may qualify if:
- Patient with drug-resistant focal epilepsy undergoing SEEG evaluation as part of the pre-surgical workup for epilepsy
- Intellectual capacity sufficient to perform cognitive tasks, receive information about the study procedure, and understand the information sheet
You may not qualify if:
- Patients already participating in another research project that prohibits participation in another study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Electrophysiologie cérébrale, épilepsie, sommeil, Hôpital Pierre Paul Riquet
Toulouse, Oui, 31000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 27, 2026
First Posted
September 1, 2026
Study Start
October 1, 2026
Primary Completion (Estimated)
October 1, 2031
Study Completion (Estimated)
October 31, 2031
Last Updated
September 1, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share